Sight threatening chemical injuries BOSU study
Research type
Research Study
Full title
Sight-threatening chemical injury study in association with the British Ophthalmological Surveillance Unit
IRAS ID
233478
Contact name
Nicola Cronbach
Contact email
Sponsor organisation
Buckinghamshire Healthcare NHS Trust
Clinicaltrials.gov Identifier
RXQ, Buckinghamshire Healthcare Trust Clinical Trials Registry
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
This study will be a survey of visual compromise resulting from chemical injury, using prospective case ascertainment through the British Ophthalmological Surveillance Unit (BOSU) monthly reporting card scheme. This is an active surveillance system involving all UK consultant ophthalmologists.
The primary aim of this study is to ascertain the incidence of sight-threatening ocular chemical injury in the UK. This is to include demographic details of patients and details of causative chemical and mechanism of injury.
The secondary aims of this study are to assess the best corrected visual acuity at presentation and 6 months, and the surgical interventions required.
This is an epidemiological study using only information available from the patient case notes. Ophthalmologists will indicate that they have seen a new case through the BOSU. The BOSU collects no patient identifying information but will notify the study investigator (Dr Cronbach) of all new cases, who will contact the reporting ophthalmologist directly.
The study will run for 12 months.REC name
South Central - Oxford B Research Ethics Committee
REC reference
18/SC/0007
Date of REC Opinion
22 Mar 2018
REC opinion
Further Information Favourable Opinion